Patent · US Active

Process for the synthesis of organic compounds

US7781597B2 · kind B2 · utility

6Cited by

1References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Stephan Abel · Weil, DE
Murat Acemoglu · Basel, CH
Bernhard Erb · Gipf-Oberfrick, CH
Christoph Max Krell · Basel, CH
Joseph A. Sclafani · Malvern, US
Mark Meisenbach · Durmenach, FR
Mahavir Prashad · East Hanover, US
Wen-Chung Shieh · Berkeley Heights, US
Song Xue · Newton, US

Key dates

Filing date	Jun 7, 2006
Grant date	Aug 24, 2010
Priority date	—
Expiry date	Sep 6, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D233/61
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.